• CJC‑1295 (with DAC) - NuroCore
  • CJC‑1295 (with DAC) - NuroCore
1 2

NuroCore

CJC‑1295 (with DAC)

CJC‑1295 (with DAC)

500.00 AED
500.00 AED
Sale Sold out
Shipping calculated at checkout.
Size

CJC-1295 with DAC is a synthetic growth hormone releasing hormone (GHRH) analog modified with a Drug Affinity Complex (DAC) to extend its half-life. It is studied for long-acting GH release, IGF-1 stimulation, and metabolic research. Within NuroCore, CJC-1295 DAC is categorized under Growth & Metabolic Research.

View full details

Concentration: Commonly 2 mg or 5 mg vials (lyophilized powder)

Composition: Synthetic GHRH analog with Drug Affinity Complex

Formulation: Lyophilized acetate salt

Half-Life: ~6–8 days with DAC modification

Primary Actions: Long-acting GH release, IGF-1 axis, metabolic studies


Shown to sustain GH release for several days in experimental models.

Studied for increasing IGF-1 levels and metabolic pathways.

Explored in longevity, recovery, and regenerative research.

Often paired with Ipamorelin for synergistic GH axis studies.


Reconstitute with bacteriostatic water (NuroCore standard).

Swirl gently until dissolved.

Handle under sterile research conditions.


Unreconstituted: Store at –20 °C.

Reconstituted: Refrigerate at 2–8 °C.

Appearance: Clear, colorless solution; discard if cloudy or particulate.

Category: Growth & Metabolic Research (NuroCore)

Use Case: Research into long-acting GH release, IGF-1 stimulation, and metabolic pathways

Compliance Note: Classified strictly as a research compound

Other customers also bought

View all